Ruishuang Ma
- Immunology top 10%
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 9
- Phagocytosis and Immune Regulation 9
- Immune cells in cancer 4
- Internal Medicine top 10%
- Hematology top 10%
- Blood Coagulation and Thrombosis Mechanisms 7
- Platelet Disorders and Treatments 6
-
- Cancer, Hypoxia, and Metabolism 4
-
- Retinoids in leukemia and cellular processes 3
-
- COVID-19 Clinical Research Studies 5
- Co-authors
- Jialan ShiJunjie KouYayan BiZengxiang DongRui XieShaohong FangJin ZhouValerie A. Novakovic
- Journals
- SHILAP Revista de lepidopterología (1 paper)Blood (3 papers)PLoS ONE (1 paper)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Ruishuang Ma
41 papers receiving 950 citations
Peers
Comparison fields: 5 of 84
- Immunology 373
- Internal Medicine 57
- Hematology 125
- Cancer Research 120
- Molecular Biology 434
Countries citing papers authored by Ruishuang Ma
This map shows the geographic impact of Ruishuang Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruishuang Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruishuang Ma more than expected).
Fields of papers citing papers by Ruishuang Ma
This network shows the impact of papers produced by Ruishuang Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruishuang Ma. The network helps show where Ruishuang Ma may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ruishuang Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 3 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 26 | |
| 7 | 2024 | 10 | |
| 8 | 2024 | 17 | |
| 9 | 2024 | 15 | |
| 10 | 2022 | 2 | |
| 11 | 2022 | 20 | |
| 12 | 2021 | 13 | |
| 13 | 2018 | 17 | |
| 14 | 2018 | 18 | |
| 15 | 2018 | 41 | |
| 16 | 2016 | 41 | |
| 17 | 2016 | 24 | |
| 18 | 2015 | 40 | |
| 19 | 2015 | 83 | |
| 20 | 2015 | 18 |
About Ruishuang Ma
Ruishuang Ma is a scholar working on Hematology, Immunology and Genetics, having authored 47 papers that have together received 958 indexed citations. Recurring topics across this work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (9 papers), Phagocytosis and Immune Regulation (9 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers), Platelet Disorders and Treatments (6 papers), COVID-19 Clinical Research Studies (5 papers), Cancer, Hypoxia, and Metabolism (4 papers), Immune cells in cancer (4 papers) and Retinoids in leukemia and cellular processes (3 papers). The work is most often cited by research in Immunology (373 citations), Internal Medicine (57 citations) and Hematology (125 citations). Ruishuang Ma has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Jialan Shi, Junjie Kou, Yayan Bi, Zengxiang Dong, Rui Xie, Shaohong Fang, Jin Zhou, Valerie A. Novakovic, Tao Jiang and Muhua Cao. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.